224 related articles for article (PubMed ID: 23409943)
1. Generation of functional platelets from canine induced pluripotent stem cells.
Nishimura T; Hatoya S; Kanegi R; Sugiura K; Wijewardana V; Kuwamura M; Tanaka M; Yamate J; Izawa T; Takahashi M; Kawate N; Tamada H; Imai H; Inaba T
Stem Cells Dev; 2013 Jul; 22(14):2026-35. PubMed ID: 23409943
[TBL] [Abstract][Full Text] [Related]
2. OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets.
Matsubara Y; Ono Y; Suzuki H; Arai F; Suda T; Murata M; Ikeda Y
PLoS One; 2013; 8(3):e58123. PubMed ID: 23469264
[TBL] [Abstract][Full Text] [Related]
3. Generation of Megakaryocytes and Platelets from Human Pluripotent Stem Cells.
Pick M
Methods Mol Biol; 2016; 1307():371-8. PubMed ID: 24297316
[TBL] [Abstract][Full Text] [Related]
4. Human endometrial stromal stem cells differentiate into megakaryocytes with the ability to produce functional platelets.
Wang J; Chen S; Zhang C; Stegeman S; Pfaff-Amesse T; Zhang Y; Zhang W; Amesse L; Chen Y
PLoS One; 2012; 7(8):e44300. PubMed ID: 22952951
[TBL] [Abstract][Full Text] [Related]
5. Generation and characterization of LIF-dependent canine induced pluripotent stem cells from adult dermal fibroblasts.
Whitworth DJ; Ovchinnikov DA; Wolvetang EJ
Stem Cells Dev; 2012 Aug; 21(12):2288-97. PubMed ID: 22221227
[TBL] [Abstract][Full Text] [Related]
6. Generation of Footprint-Free Canine Induced Pluripotent Stem Cells Using Auto-Erasable Sendai Virus Vector.
Tsukamoto M; Nishimura T; Yodoe K; Kanegi R; Tsujimoto Y; Alam ME; Kuramochi M; Kuwamura M; Ohtaka M; Nishimura K; Nakanishi M; Inaba T; Sugiura K; Hatoya S
Stem Cells Dev; 2018 Nov; 27(22):1577-1586. PubMed ID: 30215317
[TBL] [Abstract][Full Text] [Related]
7. Generation of leukemia inhibitory factor and basic fibroblast growth factor-dependent induced pluripotent stem cells from canine adult somatic cells.
Luo J; Suhr ST; Chang EA; Wang K; Ross PJ; Nelson LL; Venta PJ; Knott JG; Cibelli JB
Stem Cells Dev; 2011 Oct; 20(10):1669-78. PubMed ID: 21495906
[TBL] [Abstract][Full Text] [Related]
8. Modeling Glanzmann thrombasthenia using patient specific iPSCs and restoring platelet aggregation function by CD41 overexpression.
Hu L; Du L; Zhao Y; Li W; Ouyang Q; Zhou D; Lu G; Lin G
Stem Cell Res; 2017 Apr; 20():14-20. PubMed ID: 28232155
[TBL] [Abstract][Full Text] [Related]
9. Efficient generation of megakaryocytes from human induced pluripotent stem cells using food and drug administration-approved pharmacological reagents.
Liu Y; Wang Y; Gao Y; Forbes JA; Qayyum R; Becker L; Cheng L; Wang ZZ
Stem Cells Transl Med; 2015 Apr; 4(4):309-19. PubMed ID: 25713465
[TBL] [Abstract][Full Text] [Related]
10. Genetic Instruction of Megakaryocytes and Platelets Derived from Human Induced Pluripotent Stem Cells for Studies of Integrin Regulation.
Kasirer-Friede A; Shattil SJ
Methods Mol Biol; 2021; 2217():237-249. PubMed ID: 33215384
[TBL] [Abstract][Full Text] [Related]
11. In vitro generation of megakaryocytes and platelets from human embryonic stem cells and induced pluripotent stem cells.
Takayama N; Eto K
Methods Mol Biol; 2012; 788():205-17. PubMed ID: 22130710
[TBL] [Abstract][Full Text] [Related]
12. Packaging functionally important plasma proteins into the α-granules of human-induced pluripotent stem cell-derived megakaryocytes.
Zhang N; Newman PJ
J Tissue Eng Regen Med; 2019 Feb; 13(2):244-252. PubMed ID: 30556311
[TBL] [Abstract][Full Text] [Related]
13. Positioning canine induced pluripotent stem cells (iPSCs) in the reprogramming landscape of naïve or primed state in comparison to mouse and human iPSCs.
Menon DV; Bhaskar S; Sheshadri P; Joshi CG; Patel D; Kumar A
Life Sci; 2021 Jan; 264():118701. PubMed ID: 33130086
[TBL] [Abstract][Full Text] [Related]
14. Large-scale generation of megakaryocytes from human embryonic stem cells using transgene-free and stepwise defined suspension culture conditions.
Zhang B; Wu X; Zi G; He L; Wang S; Chen L; Fan Z; Nan X; Xi J; Yue W; Wang L; Wang L; Hao J; Pei X; Li Y
Cell Prolif; 2021 Apr; 54(4):e13002. PubMed ID: 33615584
[TBL] [Abstract][Full Text] [Related]
15. Megakaryocytes promote hepatoepithelial liver cell development in E11.5 mouse embryos by cell-to-cell contact and by vascular endothelial growth factor A signaling.
Serrano N; Cortegano I; Ruiz C; Alía M; de Andrés B; Rejas MT; Marcos MA; Gaspar ML
Hepatology; 2012 Nov; 56(5):1934-45. PubMed ID: 22611008
[TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of HLA-universal platelets derived from induced pluripotent stem cells.
Norbnop P; Ingrungruanglert P; Israsena N; Suphapeetiporn K; Shotelersuk V
Sci Rep; 2020 May; 10(1):8472. PubMed ID: 32439978
[TBL] [Abstract][Full Text] [Related]
17. Targeting expression to megakaryocytes and platelets by lineage-specific lentiviral vectors.
Latorre-Rey LJ; Wintterle S; Dütting S; Kohlscheen S; Abel T; Schenk F; Wingert S; Rieger MA; Nieswandt B; Heinz N; Modlich U
J Thromb Haemost; 2017 Feb; 15(2):341-355. PubMed ID: 27930847
[TBL] [Abstract][Full Text] [Related]
18. Generation and Neuronal Differentiation of Patient-Specific Induced Pluripotent Stem Cells Derived from Niemann-Pick Type C1 Fibroblasts.
Trilck M; Hübner R; Frech MJ
Methods Mol Biol; 2016; 1353():233-59. PubMed ID: 25520288
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of tumstatin in genetically modified megakaryocytes changes the proangiogenic effect of platelets.
Li J; Luo J; Luo YQ; Zhou M; Zhao L; Yao LJ; Dong H; Yang RN
Transfusion; 2014 Aug; 54(8):2106-17. PubMed ID: 24655355
[TBL] [Abstract][Full Text] [Related]
20. In vitro large scale production of megakaryocytes to functional platelets from human hematopoietic stem cells.
Kumar PS; Chandrasekhar C; Srikanth L; Sarma PVGK
Biochem Biophys Res Commun; 2018 Oct; 505(1):168-175. PubMed ID: 30243726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
